Launch week offerEnds in00h00m00s

annual Promonthly Pro

Renata Pacholczak-Madej

National Cancer Institute

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (25)

Collaborators (8)

Kamil Kisielewicz

Assistant Professor

Maria Sklodowska-Curie National Research Institute of Oncology

Iveta Selingerová

Masaryk Memorial Cancer Institute

CZECH REPUBLIC

Tomasz Kluz

Rzeszów University

Małgorzata Pieniążek

Wroclaw Medical University

Zuzana Bielcikova

Charles University

CZECH REPUBLIC

Dagmara Klasa-Mazurkiewicz

Medical University of Gdansk

Petra Bretová

Associate Professor

Charles University

CZECH REPUBLIC

Aleksandra Konieczna

Assistant Professor

Maria Sklodowska-Curie National Research Institute of Oncology

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Renata Pacholczak-Madej

Research Interests

Make your next move.

Explore related searches

Articles (25)

Collaborators (8)

Kamil Kisielewicz

Iveta Selingerová

Tomasz Kluz

Małgorzata Pieniążek

Zuzana Bielcikova

Dagmara Klasa-Mazurkiewicz

Petra Bretová

Aleksandra Konieczna

Make your next move.

Renata Pacholczak-Madej

Research Interests

Make your next move.

Explore related searches

Articles (25)

Immune-Related Adverse Events of Cemiplimab Therapy in Advanced Cervical Cancer—Data from the Polish–Czech Cervical Cancer Immunotherapy Group (PCCIG-01) with a Review of the Literature

Combined positive score status in metastatic triple-negative breast cancer patients treated with sacituzumab govitecan: associated clinical characteristics and testing patterns in a Central European cohort

Efficacy and safety of sacituzumab govitecan in patients with metastatic metaplastic triple-negative breast cancer: a multinational retrospective case series from CEBCC-102 study

Real-world outcomes of sacituzumab govitecan in patients with pretreated triple-negative breast cancer and brain metastases: data from CEBCC-102 study

Timing of final oncologist visit and systemic treatment use near the end of life in pretreated patients with metastatic triple-negative breast cancer: a multinational cohort study

Enhanced thrombin generation potential in male and female patients with Fabry disease: a single-center observational study

Vascular endothelial dysfunction and echocardiographic changes in male and female patients with Fabry disease: a single-center observational study

Cyclin-dependent kinase 4/6 inhibitors in granulosa cell tumors and their combination with hormonal therapy: a scoping review

Primary G-CSF prophylaxis in sacituzumab govitecan-treated mTNBC: real-world evidence from a multinational CEBCC-102 cohort

Use of dietary supplements and over-the-counter products among adults with a self-reported history of cancer in Poland

Real-world efficacy and safety of nivolumab and ipilimumab in metastatic renal cell carcinoma: a Polish multicenter study

Advances in oncology after the 2024 European Society for Medical Oncology (ESMO) congress

Clinicopathological Features and Risk Stratification of Multiple-Classifier Endometrial Cancers: A Multicenter Study from Poland

Effectiveness and safety of nivolumab and ipilimumab in older adults with renal cell carcinoma: findings from a multicenter observational study in Poland

Exploring the efficacy of nivolumab and ipilimumab in renal cell carcinoma: insights from a district hospital cohort study

Exploring the efficacy of nivolumab and ipilimumab in renal cell carcinoma: insights from a district hospital cohort study

Immune-related adverse events to predict outcomes in recurrent/metastatic cervical cancer treated with cemiplimab: Insights from a rescue access program in Poland

Integrating locoregional therapy with ongoing immunotherapy after oligoprogression in recurrent/metastatic cervical cancer

Prognostic significance of peripheral blood biomarkers in patients with advanced renal cell carcinoma treated with nivolumab and ipilimumab-a polish multicenter, observational study

Prognostic significance of peripheral blood biomarkers in patients with advanced renal cell carcinoma treated with nivolumab and ipilimumab—a polish multicenter, observational study

Effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer: A real-world retrospective cohort study from central Europe

18-Hour Planar Scintigraphy Versus SPECT/CT for Sentinel Lymph Node Detection in Early-Stage Endometrial Cancer

Sacituzumab Govitecan initial dose reduction in polish patients with metastatic triple-negative breast cancer: impact on efficacy and safety

Strategies for premedication and G-CSF application in sacituzumab govitecan treatment of patients with triple-negative breast cancer: multicenter insights

Bispecific antibodies and their conjugates in solid tumors and hematological malignancies

Collaborators (8)

Kamil Kisielewicz

Iveta Selingerová

Tomasz Kluz

Małgorzata Pieniążek

Zuzana Bielcikova

Dagmara Klasa-Mazurkiewicz

Petra Bretová

Aleksandra Konieczna

Make your next move.